Pharmafile Logo
Pharmafocus logo
Advanced Search

Dr Clive Deverson

November 23, 2015

OmniaMed UK appoints new senior management OmniaMed strengthens its senior management team by appointing Dr Clive Deverson as Managing Director …

Appointment
tablets_red

Take the Pharmafocus reader survey today

November 23, 2015
Manufacturing and Production, Research and Development

As a valued reader of Pharmafocus, you regularly receive print copies of our market-leading newspaper and have access to the digital …

Feature
pfizer_hq_new_york_dark

Pfizer and Allergan confirm record $160 billion merger

November 23, 2015
Manufacturing and Production, Research and Development

Pfizer and Allergan have confirmed a $160 billion merger, unanimously approved by their boards of directors, creating the world’s largest …

News
Takeda oncology

FDA approves Takeda’s Ninlaro for multiple myeloma

November 23, 2015
Manufacturing and Production, Research and Development Takeda, myeloma

The US Food and Drug Administration (FDA) has approved Takeda’s Ninlaro (ixazomib) for use in combination with lenalidomide and dexamethasone …

News
pfizer_logo

Pfizer and Allergan on brink of $150 billion merger

November 23, 2015
Sales and Marketing

Pfizer is reported to have secured formal board approval for a deal worth more than $150 billion to merge with …

News
cosentyx_logo

Novartis bags two EU Cosentyx approvals

November 23, 2015
Research and Development, Sales and Marketing

The European Commission (EC) has approved Novartis’ Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and …

News
horizon_pharma

Horizon withdraws $1bn Depomed bid

November 20, 2015
Sales and Marketing

Horizon Pharma has withdrawn its $1 billion unsolicited offer for Depomed following a block from a California court based on Horizon’s inappropriate …

News
amgen_flag

European Commission approves Amgen’s cancer drug Kyprolis in combo therapy

November 20, 2015
Research and Development, Sales and Marketing

The European Commission (EC) has today granted marketing authorization for Amgen’s Kyprolis (carfilzomib) in combination with lenalidomide and dexamethasone for …

News
ema_logo

Bioproject’s narcolepsy treatment recommended for European approval

November 20, 2015
Research and Development, Sales and Marketing

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Bioproject’s Wakix (pitolisant) for the treatment of narcolepsy …

News
ema_inside

Biogen’s Enbrel biosimilar gets positive CHMP opinion

November 20, 2015
Research and Development, Sales and Marketing

The Committee for Medicinal Products for Human Use (CHMP) today gave a positive opinion to Benepali- the first biosimilar version …

News
martin_shkreli_smaller_same

Turing boss Shkreli joins KaloBios as CEO; takes 70% of shares

November 20, 2015
Medical Communications, Research and Development

KaloBios Pharmaceuticals has announced the appointment of Turing CEO Martin Shkreli as its own new CEO and his election as …

Appointment
dr_allan_dunton

Alan Dunton appointed senior vice president at Purdue Pharma

November 20, 2015
Manufacturing and Production, Medical Communications, Research and Development

Purdue Pharma LP has announced the appointment of Alan Dunton, MD, to the role of senior vice president of Research …

Appointment
keytruda

Lilly and Merck extend immuno-oncology collaboration

November 20, 2015
Medical Communications, Research and Development Eli Lilly, Merck

Eli Lilly and Merck have announced the extension of their existing collaboration to evaluate the safety and efficacy of the …

News
bayercross3

Bayer awaits FDA decision on new contraceptive

November 20, 2015
Medical Communications, Research and Development

Bayer has submitted a new drug application (NDA) to the FDA, seeking approval for LCS-16, an investigational hormonal intrauterine device …

News
abpi_logo_on_wall

PMCPA rules on two Bayer conduct breach allegations

November 20, 2015
Medical Communications, Sales and Marketing

The pharma industry regulator in the UK, the PMCPA, has ruled on two alleged breaches of the ABPI code of …

News
Turing logo

Top five pharma controversies of 2015 (so far)

November 20, 2015
Medical Communications, Sales and Marketing AstraZeneca, Martin Shkreli, Philidore, Takeda, Turing Pharmaceutical, Valeant, Warner Chilcott, controversies, fraud, reputation, tax avoidance, turing

5. AstraZeneca forced to deny tax avoidance allegations

Feature

New partner drives Simon-Kucher’s Life Sciences growth in the UK

November 19, 2015
Medical Communications

The global strategy and marketing consultancy Simon-Kucher & Partners has appointed eleven new partners for 2016, with eight of them …

Appointment
lyrica_advert

American Medical Association calls for ban on drug commercials

November 19, 2015
Medical Communications, Sales and Marketing

The American Medical Association (AMA) has called for a ban on the promotion of prescription products; action which it believes …

News
nhs_england_and_nice_logos

NHS England and NICE announce plans for new Cancer Drugs Fund

November 19, 2015
Medical Communications, Research and Development Cancer Drugs Fund, NHS England, NICE

A 12-week consultation on draft proposals for a revamped Cancer Drugs Fund (CDF) has been launched by NHS England and NICE, …

News

Physicians Interactive becomes Aptus Health, offering a global digital health engagement solution

November 19, 2015
Medical Communications

Physicians Interactive has announced that it has become Aptus Health, reflecting its mission of advancing health engagement and its role …

News
Press release
The Gateway to Local Adoption Series

Latest content

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026

Vetter begins construction of new injectable medicines facility

May 20, 2026